Development of a telematic pharmaceutical care app (Haemoassist) for multidisciplinary follow-up of patients with congenital coagulopathies.

Nuria Blazquez-RamosJosé A Romero-GarridoLuis Gonzalez Del ValleVictoria L Collada-SanchezMaría Teresa Alvarez-RomanVictor Jimenez-YusteMonica Martin-SalcesAlicia Herrero-AmbrosioJuana Benedi-Gonzalez Emérito Carlos Rodríguez Merchán

Published in: Expert review of hematology (2022)

Healthcare professionals valued the app as useful for managing treatment of congenital coagulopathies. Patients need support and time to use the app and improve the quality of the data entered. Patients who used the app rated it positively. The treatment compliance improved.

Keyphrases

end stage renal disease
quality improvement
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
electronic health record
chronic pain
patient reported outcomes
smoking cessation
artificial intelligence